Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
 
  
   
Insider Information:   Steiner Mitchell Shuster
Relationship:   President and CEO, Dir...
City:   Memphis
State:   TN
   
Insider Summary:
  
   
Companies Owned :   2    
Direct Shares   9,072,631    

Indirect Shares

   2,687,445      
Direct Value   $7,741,847    

Indirect Value

   $1,016,824      
Total Shares   11,760,076      
Total Value   $8,758,672      


Oncternal Therapeutics Inc $729,711 Veru Inc $7,012,136 Oncternal Therapeutics Inc $729,711 Veru Inc $7,012,136
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :
    0   
    8    

     Stock price went up :
    0   
    0    
     Stock price went down :
    0   
    8    
   
     Gain/Loss Ratio :
   0.0   
   -8.0   
     Percentage Gain/Loss :
     0.0%
 -230.3%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Oncternal Therapeutics Inc ONCT Chief Executive Office... 2012-07-16 2,129,922 2012-07-16 2,543,445    Premium*  
            Veru Inc VERU President and CEO, Dir... 2024-05-24 6,942,709 2024-05-24 144,000    Premium*  
* Premium Members only  

Records found :    148         Free Registration Required For Full Results.    Limit: 25

 Download
  Page 3 of 6
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

  
3m +/-  
Form
VERU Veru Inc President and CEO   •       •       •   2018-03-12 4 B $1.73 $17,296 I/I 10,000 45,000 2.56 -
VERU Veru Inc President and CEO   •       •       •   2018-03-13 4 B $1.77 $17,709 I/I 10,000 47,500 2.56 -
VERU Veru Inc President and CEO   •       •       •   2018-03-09 4 B $1.82 $18,200 I/I 10,000 42,500 2.56 -
VERU Veru Inc President and CEO   •       •       •   2018-03-08 4 B $1.88 $37,552 I/I 20,000 40,000 2.64 -
VERU Veru Inc President and CEO   •       •       •   2019-09-05 4 AS $1.92 $10,743 D/D (5,610) 7,525,153 0 -
VERU Veru Inc President and CEO   •       •       •   2019-09-06 4 AS $1.92 $13,208 D/D (6,890) 7,518,263 0 -
VERU Veru Inc President and CEO   •       •       •   2019-09-04 4 AS $1.94 $33,968 D/D (17,500) 7,530,763 0 -
VERU Veru Inc President and CEO   •       •       •   2018-03-16 4 B $1.96 $39,266 I/I 20,000 52,500 2.64 -
VERU Veru Inc President and CEO   •       •       •   2019-06-05 4 AS $1.98 $39,560 D/D (20,000) 7,598,263 0 -
VERU Veru Inc President and CEO   •       •       •   2019-11-06 4 AS $1.99 $35,025 D/D (17,618) 7,470,645 0 -
VERU Veru Inc President and CEO   •       •       •   2019-11-07 4 AS $2.00 $14,742 D/D (7,382) 7,463,263 0 -
VERU Veru Inc President and CEO   •       •       •   2019-10-11 4 AS $2.01 $15,889 D/D (7,897) 7,488,263 0 -
VERU Veru Inc President and CEO   •       •       •   2019-10-10 4 AS $2.10 $13,880 D/D (6,600) 7,496,160 0 -
VERU Veru Inc President and CEO   •       •       •   2019-10-03 4 AS $2.11 $11,109 D/D (5,260) 7,507,928 0 -
VERU Veru Inc President and CEO   •       •       •   2019-10-04 4 AS $2.11 $8,087 D/D (3,829) 7,504,099 0 -
VERU Veru Inc President and CEO   •       •       •   2019-10-09 4 AS $2.11 $2,824 D/D (1,339) 7,502,760 0 -
VERU Veru Inc President and CEO   •       •       •   2019-10-02 4 AS $2.12 $10,758 D/D (5,075) 7,513,188 0 -
VERU Veru Inc President and CEO   •       •       •   2019-12-04 4 AS $2.20 $18,494 D/D (8,410) 7,451,357 0 -
VERU Veru Inc President and CEO   •       •       •   2019-12-05 4 AS $2.22 $36,846 D/D (16,590) 7,434,767 0 -
VERU Veru Inc President and CEO   •       •       •   2019-07-03 4 AS $2.25 $44,980 D/D (20,000) 7,578,263 0 -
VERU Veru Inc President and CEO   •       •       •   2019-08-07 4 AS $2.26 $67,830 D/D (30,000) 7,548,263 0 -
ONCT Oncternal Therapeutics In... Chief Executive Officer   •       •       •   2012-04-12 4 S $3.50 $3,980 I/I (1,137) 1,992,986 0 -
ONCT Oncternal Therapeutics In... Chief Executive Officer   •       •       •   2012-04-11 4 S $3.51 $93,313 I/I (26,585) 1,994,123 0 -
ONCT Oncternal Therapeutics In... Chief Executive Officer   •       •       •   2012-04-10 4 S $3.59 $16,160 I/I (4,500) 2,020,708 0 -
ONCT Oncternal Therapeutics In... Chief Executive Officer   •       •       •   2012-04-09 4 S $3.66 $142,264 I/I (38,923) 2,025,208 0 -
  148  Records found
  1   2   3  4   5   6      
  Page 3 of 6  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us